Procaps Group S.A. (PROC)

NASDAQ: PROC · Real-Time Price · USD
2.210
-0.050 (-2.21%)
Dec 12, 2024, 9:41 AM EST - Market open
-2.21%
Market Cap 249.34M
Revenue (ttm) 414.10M
Net Income (ttm) 52.20M
Shares Out 112.82M
EPS (ttm) 0.52
PE Ratio 4.38
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,277
Open 2.210
Previous Close 2.260
Day's Range 2.205 - 2.270
52-Week Range 0.500 - 4.950
Beta 0.10
Analysts n/a
Price Target n/a
Earnings Date Dec 17, 2024

About PROC

Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use, such as antibiotic, blood clot, personal protective equipment, immunosuppressant, oncology, and analgesics products. In addition, the company offers ... [Read more]

Sector Healthcare
Founded 1976
Employees 5,500
Stock Exchange NASDAQ
Ticker Symbol PROC
Full Company Profile

Financial Performance

Financial Statements

News

Procaps Group Announces Financing, Shareholders Agreement and Board Updates

MIAMI and BARRANQUILLA, Colombia , Dec. 03, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services ...

8 days ago - GlobeNewsWire

Procaps Receives Nasdaq Listing Determination; To Request Hearing and Further Stay Pending Hearing

MIAMI and BARRANQUILLA, Colombia, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), announced today that, on November 13, 2024, the Company received fo...

26 days ago - GlobeNewsWire

Procaps Issues Shareholder Letter Update

MIAMI and BARRANQUILLA, Colombia, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services, ...

2 months ago - GlobeNewsWire

Procaps Issues Shareholder Letter

MIAMI and BARRANQUILLA, Colombia, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical conglomer...

3 months ago - GlobeNewsWire

Procaps Group Announces New Chairman

MIAMI & BARRANQUILLA, Columbia--(BUSINESS WIRE)--Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced that ...

5 months ago - Business Wire

Procaps Group Receives Nasdaq Notice Related to Late Filing of its Form 20-F

MIAMI & BARRANQUILLA, Colombia--(BUSINESS WIRE)--Procaps Group Receives Nasdaq Notice Related to Late Filing of its Form 20-F.

7 months ago - Business Wire

Procaps Group Delays Filing of Annual Report on Form 20-F

MIAMI & BARRANQUILLA, Colombia--(BUSINESS WIRE)--Procaps Group Delays Filing of Annual Report on Form 20-F.

7 months ago - Business Wire

Procaps Group – Notice to Shareholders

MIAMI & BARRANQUILLA, Colombia.--(BUSINESS WIRE)--Dear Shareholders, We became aware on Saturday, January 13, 2024, that the online voting instructions related to the upcoming General Meeting of Share...

11 months ago - Business Wire

Procaps Group Reports Third Quarter 2023 Results

MIAMI & BARRANQUILLA, Colombia--(BUSINESS WIRE)--Procaps Group Reports Third Quarter 2023 Results.

1 year ago - Business Wire

Statement from the Board of Directors of Procaps Group

MIAMI & BARRANQUILLA, Colombia--(BUSINESS WIRE)--Statement from the Board of Directors of Procaps Group.

1 year ago - Business Wire

Procaps Group and Genomma Lab Announce a Strategic Agreement to Manufacture and Market Softgel Products in Latin America

Agreement Combines Procaps Oral Delivery System Technology and Manufacturing with Genomma's Strategic Marketing and Distribution Footprint BARRANQUILLA, Colombia and MEXICO CITY and MIAMI , Nov. 29, 2...

1 year ago - PRNewsWire

Procaps Group Announces Appointment of Jose Antonio Vieira as Chief Executive Officer Starting 2024

MIAMI & BARRANQUILLA, Colombia--(BUSINESS WIRE)--Procaps Group Announces Appointment of Jose Antonio Vieira as Chief Executive Officer Starting 2024.

1 year ago - Business Wire

Procaps Group Update on Third Quarter Results

MIAMI & BARRANQUILLA, Colombia--(BUSINESS WIRE)--Procaps Group Update on Third Quarter Results.

1 year ago - Business Wire

Procaps Group to Report Third Quarter and Nine Months 2023 Results on Tuesday November 14, 2023

MIAMI & BARRANQUILLA, Colombia--(BUSINESS WIRE)--Procaps Group to Report Third Quarter and Nine Months Results on Tuesday November 14 and Host Conference Call on Thursday November 16 at 10:30a.m. ET.

1 year ago - Business Wire

Procaps Group Wins First Place in Ranking of Innovative Companies in the Pharma Sector in Colombia

MIAMI & BARRANQUILLA, Colombia--(BUSINESS WIRE)--Procaps Group Wins First Place in Ranking of Innovative Companies in the Pharma Sector in Colombia.

1 year ago - Business Wire

Procaps Group to Participate at CPHI Barcelona 2023

MIAMI & BARRANQUILLA, Colombia--(BUSINESS WIRE)--Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced today that it will participa...

1 year ago - Business Wire

Procaps Group to Host Webinar on Colombian Pharma Market

MIAMI & BARRANQUILLA, Colombia--(BUSINESS WIRE)--Procaps Group to Host Webinar on Colombian Pharma Market Tuesday, October 10, 2023 at 10:00 a.m. Eastern Time.

1 year ago - Business Wire

Procaps Group to Participate at BTG 2023 LatAm CEO Conference and Roth 2023 Healthcare Opportunities Conference in October

MIAMI & BARRANQUILLA, Colombia--(BUSINESS WIRE)--Procaps Group to Participate at BTG 2023 LatAm CEO Conference and Roth 2023 Healthcare Opportunities Conference in October.

1 year ago - Business Wire

Procaps Group Announces the Expansion of its Oncology Portfolio

MIAMI & BARRANQUILLA, Columbia--(BUSINESS WIRE)--Procaps Group Announces the Expansion of its Oncology Portfolio.

1 year ago - Business Wire

Procaps Group S.A. (PROC) Q2 2023 Earnings Call Transcript

Procaps Group S.A. (NASDAQ:PROC) Q2 2023 Earnings Call Transcript September 5, 2023 11:00 AM ET Company Participants Melissa Angelini - IR Director Ruben Minski - CEO Patricio Vargas - CFO Conference...

1 year ago - Seeking Alpha

Procaps Group Reports Second Quarter 2023 Results

MIAMI & BARRANQUILLA, Colombia--(BUSINESS WIRE)--Procaps Group Reports Second Quarter 2023 Results.

1 year ago - Business Wire

Procaps Group to Report Second Quarter and First Half 2023 Results and Host Conference Call on Tuesday

MIAMI & BARRANQUILLA, Colombia--(BUSINESS WIRE)--Procaps Group to Report Second Quarter and First Half 2023 Results and Host Conference Call on Tuesday.

1 year ago - Business Wire

Procaps Group Publishes White Paper on Innovative Gummy Technology

MIAMI & BARRANQUILLA, Colombia--(BUSINESS WIRE)--Procaps Group Publishes White Paper on Innovative Gummy Technology.

1 year ago - Business Wire

Procaps Group Reports First Quarter 2023 Results

Constant Currency Net Revenues Increased 10% Quarter-over-Quarter in 1Q23, and 22% increase in Adjusted EBITDA, With Strong Demand of RX and Softgel Portfolios, Offset by Clinical Specialty Covid Port...

1 year ago - GlobeNewsWire

Procaps Group Reports Fourth Quarter and Full Year 2022 Results

MIAMI & BARRANQUILLA, Colombia--(BUSINESS WIRE)--Procaps Group Reports Fourth Quarter and Full Year 2022 Results.

1 year ago - Business Wire